secwatch.observer — SEC 8-K summary
======================================

Issuer:     Wellgistics Health, Inc. (WGRX)
CIK:        0002030763
Form:       8-K/A
Filed at:   2025-11-26T23:59:59+00:00
Accession:  0001493152-25-025072
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Wellgistics licenses DataVault AI smart contract IP for PharmacyChain; $2.5M upfront plus royalties
--------------------------------------------------------------------------------

- Upfront license fee of $2.5M due by Dec 31, 2025; ongoing 13% royalty on PharmacyChain net profit.
- Minimum annual royalty of $1M from 2028, waived if PharmacyChain net profit under $2M in 2028-2029.
- DataVault receives 90% of any sublicensing revenue Wellgistics generates from the licensed IP.
- Exclusive license for DataVault's smart contract patents in prescription drug distribution; Wellgistics to build PharmacyChain platform.
- Wellgistics expects to integrate with EinsteinRx AI, targeting disruption of PBM rebate system in $634B US drug market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2030763/000149315225025072/0001493152-25-025072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2030763/000149315225025072/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-025072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer